FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Kingfisher confirms full-year guidance after resilient Q1

Kingfisher said it remains on track to meet full-year guidance after a resilient first quarter, with growth in e-commerce, trade sales and marketplace activity offsetting softer seasonal demand...

Melrose Industries’ GKN Garden Grove MMA tank incident update

Melrose Industries' GKN Aerospace continues to work with emergency services and authorities following a thermal issue involving an MMA storage tank at its Garden Grove facility. Authorities have confirmed reduced..

AstraZeneca’s Enhertu recommended for EU approval in HER2-positive solid tumours

AstraZeneca and Daiichi Sankyo’s Enhertu has received a positive CHMP opinion for adults with previously treated unresectable or metastatic HER2-positive solid tumours who have no satisfactory treatment options...

Games Workshop expects core revenue of at least £625m for FY2026

Games Workshop estimates core revenue of not less than £625 million and profit before tax of not less than £265 million for the 52 weeks ending 31 May 2026. Its..

Smiths lowers FY2026 revenue guidance after Middle East disruption

Smiths reported flat organic revenue growth in Q3 and now expects FY2026 organic revenue growth of around 2%, while maintaining profit expectations and continuing portfolio reshaping...

Sage Group lifts FY26 outlook after strong first-half growth

Sage reported 11% underlying revenue growth to £1.36bn and a 15% rise in underlying operating profit for the first half, supported by cloud momentum, AI adoption and strong cash conversion...

ICG reports strong FY26 results as fee-related earnings rise 23%

ICG delivered AUM of $126bn and fundraising of $17bn for the year ended 31 March 2026, with fee-related earnings up 23% to £350m and a 16th consecutive annual dividend increase...

Marks & Spencer FY2026 profit falls despite strong food performance

Marks & Spencer reported a 23.8% decline in adjusted profit before tax to £671.4m, as disruption from a cyber incident weighed on Fashion, Home & Beauty. Food sales rose 7.0%,..

British Land reports record leasing and stronger earnings outlook

British Land said record leasing activity supported rental growth and a stronger earnings outlook, with underlying profit up 5% to £294m and portfolio occupancy at 96.9%...

Severn Trent raises earnings outlook after £1.9bn investment year

Severn Trent reported strong FY26 growth, with revenue up 16.6%, PBIT up 45.9% and capital investment reaching £1.9bn, while upgrading its 2028 adjusted EPS outlook to at least 250p...

Experian reports record FY26 performance

Experian delivered 13% revenue growth and 15% Benchmark EPS growth in FY26, supported by strong regional performance, margin expansion, and a new US$1bn share repurchase programme...

HSBC begins two-day Asia investor seminar in Hong Kong

HSBC’s Asia Seminar opens in Hong Kong with presentations, Q&A and product demonstrations focused on its Asia business, including Hong Kong, Hang Seng Bank and Corporate and Institutional Banking...

Standard Chartered sets new growth targets and investment plans

Standard Chartered plans to invest in wealth, corporate banking and technology to support long-term growth, targeting RoTE above 15% by 2028 and around 18% by 2030...

DCC reports strategic progress and profit growth for FY2026

DCC reported a 3.6% rise in adjusted continuing operating profit to £634.0 million, with adjusted EPS up 9.9%, strong cash conversion and a proposed 5.0% dividend increase...

Diploma upgrades FY26 guidance after strong first half

Diploma reported 17% revenue growth and 36% adjusted EPS growth in H1 2026, driven by strong organic performance and acquisitions, and raised its FY26 guidance...

IG Group upgrades 2026 outlook after strong first-quarter revenue growth

IG Group reported a 19% rise in organic first-quarter revenue to £331.2 million, supported by higher trading activity, customer growth and momentum in stock trading and crypto. The Group raised..

Fresnillo to highlight strong 2025 performance at AGM

Fresnillo Chairman Alejandro Baillères is expected to tell shareholders that 2025 was an exceptional year, supported by higher precious metals prices, improved operations and cost discipline...

Anglo American to sell Australian steelmaking coal portfolio to Dhilmar

Anglo American has agreed to sell its Australian steelmaking coal assets to Dhilmar for up to US$3.875 billion, with proceeds used to reduce net debt...

Japan expands approval of GSK’s Arexvy to at-risk adults aged 18–49

GSK says Japan has expanded Arexvy eligibility to adults aged 18–49 at increased risk of RSV disease, including immunocompromised patients...

AstraZeneca and Daiichi Sankyo secure FDA approval for Enhertu in early breast cancer

The FDA has approved AstraZeneca and Daiichi Sankyo’s Enhertu for both neoadjuvant and adjuvant treatment of HER2-positive early breast cancer, based on results from the Phase III DESTINY-Breast11 and DESTINY-Breast05..
Search

Funds

FTSE 100

Kingfisher confirms full-year guidance after resilient Q1

Kingfisher said it remains on track to meet full-year guidance after a resilient first quarter, with growth in e-commerce, trade sales and marketplace activity offsetting softer seasonal demand...

Melrose Industries’ GKN Garden Grove MMA tank incident update

Melrose Industries' GKN Aerospace continues to work with emergency services and authorities following a thermal issue involving an MMA storage tank at its Garden Grove facility. Authorities have confirmed reduced evacuation orders and no injuries, leaks or contamination...

AstraZeneca’s Enhertu recommended for EU approval in HER2-positive solid tumours

AstraZeneca and Daiichi Sankyo’s Enhertu has received a positive CHMP opinion for adults with previously treated unresectable or metastatic HER2-positive solid tumours who have no satisfactory treatment options...

Games Workshop expects core revenue of at least £625m for FY2026

Games Workshop estimates core revenue of not less than £625 million and profit before tax of not less than £265 million for the 52 weeks ending 31 May 2026. Its 2026 Annual Report is due on 28 July 2026...

Smiths lowers FY2026 revenue guidance after Middle East disruption

Smiths reported flat organic revenue growth in Q3 and now expects FY2026 organic revenue growth of around 2%, while maintaining profit expectations and continuing portfolio reshaping...

Sage Group lifts FY26 outlook after strong first-half growth

Sage reported 11% underlying revenue growth to £1.36bn and a 15% rise in underlying operating profit for the first half, supported by cloud momentum, AI adoption and strong cash conversion. The group now expects FY26 organic revenue growth to exceed 9%...

ICG reports strong FY26 results as fee-related earnings rise 23%

ICG delivered AUM of $126bn and fundraising of $17bn for the year ended 31 March 2026, with fee-related earnings up 23% to £350m and a 16th consecutive annual dividend increase...

Marks & Spencer FY2026 profit falls despite strong food performance

Marks & Spencer reported a 23.8% decline in adjusted profit before tax to £671.4m, as disruption from a cyber incident weighed on Fashion, Home & Beauty. Food sales rose 7.0%, while the group maintained transformation investment and increased its full-year dividend to 4.2p...

British Land reports record leasing and stronger earnings outlook

British Land said record leasing activity supported rental growth and a stronger earnings outlook, with underlying profit up 5% to £294m and portfolio occupancy at 96.9%...

Severn Trent raises earnings outlook after £1.9bn investment year

Severn Trent reported strong FY26 growth, with revenue up 16.6%, PBIT up 45.9% and capital investment reaching £1.9bn, while upgrading its 2028 adjusted EPS outlook to at least 250p...

Experian reports record FY26 performance

Experian delivered 13% revenue growth and 15% Benchmark EPS growth in FY26, supported by strong regional performance, margin expansion, and a new US$1bn share repurchase programme...

HSBC begins two-day Asia investor seminar in Hong Kong

HSBC’s Asia Seminar opens in Hong Kong with presentations, Q&A and product demonstrations focused on its Asia business, including Hong Kong, Hang Seng Bank and Corporate and Institutional Banking...

Standard Chartered sets new growth targets and investment plans

Standard Chartered plans to invest in wealth, corporate banking and technology to support long-term growth, targeting RoTE above 15% by 2028 and around 18% by 2030...

DCC reports strategic progress and profit growth for FY2026

DCC reported a 3.6% rise in adjusted continuing operating profit to £634.0 million, with adjusted EPS up 9.9%, strong cash conversion and a proposed 5.0% dividend increase...

Diploma upgrades FY26 guidance after strong first half

Diploma reported 17% revenue growth and 36% adjusted EPS growth in H1 2026, driven by strong organic performance and acquisitions, and raised its FY26 guidance...

IG Group upgrades 2026 outlook after strong first-quarter revenue growth

IG Group reported a 19% rise in organic first-quarter revenue to £331.2 million, supported by higher trading activity, customer growth and momentum in stock trading and crypto. The Group raised its 2026 revenue guidance and medium-term growth outlook...

Fresnillo to highlight strong 2025 performance at AGM

Fresnillo Chairman Alejandro Baillères is expected to tell shareholders that 2025 was an exceptional year, supported by higher precious metals prices, improved operations and cost discipline...

Anglo American to sell Australian steelmaking coal portfolio to Dhilmar

Anglo American has agreed to sell its Australian steelmaking coal assets to Dhilmar for up to US$3.875 billion, with proceeds used to reduce net debt...

Japan expands approval of GSK’s Arexvy to at-risk adults aged 18–49

GSK says Japan has expanded Arexvy eligibility to adults aged 18–49 at increased risk of RSV disease, including immunocompromised patients...

AstraZeneca and Daiichi Sankyo secure FDA approval for Enhertu in early breast cancer

The FDA has approved AstraZeneca and Daiichi Sankyo’s Enhertu for both neoadjuvant and adjuvant treatment of HER2-positive early breast cancer, based on results from the Phase III DESTINY-Breast11 and DESTINY-Breast05 trials...
Search

Funds

FTSE 100

FTSE 100

Funds